Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs

Over-expression of EGFR, as in most cases of ovarian cancer, is associated with advanced-stage disease and poor prognosis. Activation of EGFR signaling pathway is involved in increased cell proliferation, angiogenesis, metastasis, and decreased apoptosis. Tyrosine kinase activity is essential for si...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cao, Cong, Lu, Shan, Sowa, Alex, Kivlin, Rebecca, Amaral, Ashley, Chu, Wenming, Yang, Hui, Di, Wen, Wan, Yinsheng
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2519958/
https://ncbi.nlm.nih.gov/pubmed/18400375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2008.02.062
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares